NewsBenzingaViking Therapeutics宣布VK2735维持研究的顶线结果,VK2735是GLP-1和葡萄糖依赖性胰岛素促泌多肽受体的双重激动剂;在第33周使用17.5毫克VK2735每周剂量后报告了22%的安慰剂调整体重减轻;未观察到平台期 Viking Therapeutics宣布VK2735维持研究的顶线结果,VK2735是GLP-1和葡萄糖依赖性胰岛素促泌多肽受体的双重激动剂;在第33周使用17.5毫克VK2735每周剂量后报告了22%的安慰剂调整体重减轻;未观察到平台期 Benzinga 2026.09.22 11:07 (GMT+0) Open on Benzinga Other news Hearing Nvidia Chair Says Jensen Huang Not Coming Back Here’s How Much You Would Have Made Owning KLA Stock In The Last 20 Years Freedom Broker Maintains Buy on Euroseas, Raises Price Target to $96 Sam Altman says his life is so weird that he’s unphased by Andrew Garfield portraying him in upcoming movie Freedom Broker Maintains Buy on JD.com, Lowers Price Target to $40 I Used This Options Strategy to Profit from the Post-IPO Plunge in SpaceX. Now I’ll Use It Again on ANT Stock After Anthropic Starts Trading.
Sam Altman says his life is so weird that he’s unphased by Andrew Garfield portraying him in upcoming movie
I Used This Options Strategy to Profit from the Post-IPO Plunge in SpaceX. Now I’ll Use It Again on ANT Stock After Anthropic Starts Trading.